CHA2DS2-VASc score

There are 73 papers on CHA2DS2-VASc score in aging research: 4 trials and 65 observational studies in people, 3 reviews. The newest story, Oct 26, 2026: “Sleep apnea linked to higher combined death, heart and stroke risk”.

Biomarker

73 papers study it19 more mention it18 findings

11 new papers in 30 daysSee all 92 papers on CHA2DS2-VASc score

“CHA2DS2-VASc > 0 and HAS-BLED > 0 were strongly associated with frailty (odds ratio [OR] 13.3 (95% CI: 11.6-15.2) for CHA2DS2-VASc 4+”
Association of CHA₂DS₂-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF studyAmerican heart journal2023doi:10.1016/j.ahj.2023.03.015
  • Human trial4
  • Humans65
  • In silico1

Effects

1

Initiation of anticoagulation

no changein humans1OR 1.16

1 study
  1. CHA2DS2-VASc score was not clearly linked with initiation of anticoagulation in humans (Patients with atrial fibrillation presenting to acute medical services) (OR 1.16, 95% CI 0.83–1.61; P = 0.38).

    “The CHA2 DS2 -VASc score was not associated with being started on anticoagulation”

    HumansPatients with atrial fibrillation presenting to acute medical servicesn = 613

    Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services

    Internal medicine journal

Upstream

1

Left atrial diameter

upin humans1

1 study
  1. Left atrial diameter is linked with better CHA2DS2-VASc score in humans (AUC increase = 0.168, P < 0.001).

    “Incorporating LAD and E/A ratios into the CHA2DS2-VASc score improved its predictive accuracy (AUC increase = 0.168, P < 0.001).”

    Humansn = 2,615

    Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

    Aging clinical and experimental research

More on Left atrial diameter

Associations

12

Mortality

upin humans4HR 1.29–1.78

4 studies
  1. CHA2DS2-VASc score is associated with mortality in humans after non-laser transvenous lead extraction (Spearman's r = 0.983, p<0.001).

    “Mortality increased progressively with higher CHA2DS2-VASc scores (Spearman's r = 0.983, p<0.001).”

    Humansafter non-laser transvenous lead extractionn = 3,822

    CHA₂DS₂-VASc and CHA₂DS₂-VA Scores as Predictors of Short- and Long-Term Mortality Following Transvenous Lead Extraction

    Vascular health and risk management

  2. CHA2DS2-VASc score predicts mortality in persons with AF (HR 1.29/score).

    “CHA2DS2-VASc scores were significantly associated with death within 10 years (HR 1.29/score).”

    Humansin persons with AF10 yearsn = 341

    Prevalence of Atrial Fibrillation and Long-Term Survival of Older Adults; Findings from the SNAC Study

    Gerontology & geriatric medicine

  3. CHA2DS2-VASc score predicts mortality in humans (coronary artery disease and atrial fibrillation) (HR 1.78, 95% CI 1.45-2.18).

    “for patients with CHA2DS2-VASc score ≥5, the adjusted hazard ratio for death was 1.78 (95% CI: 1.45-2.18, P < 0.001)”

    Humanscoronary artery disease and atrial fibrillationat least 1-year follow-upn = 1,579

    Assessment of the CHA₂DS₂-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation

    Frontiers in cardiovascular medicine

  4. CHA2DS2-VASc score predicts mortality in humans (multivariate analysis in ICD patients).

    “higher NYHA class, creatinine level and CHA2DS2-VASc score were identified as independent predictors of death”

    Humansmultivariate analysis in ICD patients

    Implantable cardioverter-defibrillators in elderly patients: outcome and predictors of mortality

    Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

Frailty

upin humans2OR 13.3

2 studies
  1. CHA2DS2-VASc score is associated with frailty in patients with AF (OR 13.3 (95% CI: 11.6-15.2)).

    “CHA2DS2-VASc > 0 and HAS-BLED > 0 were strongly associated with frailty (odds ratio [OR] 13.3 (95% CI: 11.6-15.2) for CHA2DS2-VASc 4+”

    Humansin patients with AF

    Association of CHA₂DS₂-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF study

    American heart journal

  2. Frailty is associated with CHA2DS2-VASc score in humans (Atrial fibrillation).

    “Frailty status was positively associated with the CHA2DS2-VASc score (P<0.001) and the HAS-BLED score (P=0.01).”

    HumansAtrial fibrillationn = 365

    Clinical implication of frailty assessment in older patients with atrial fibrillation

    Archives of gerontology and geriatrics

Cognitive and functional performance

downin humans1

1 study
  1. CHA2DS2-VASc score is associated with cognitive and functional performance in humans.

    “Higher CHA2DS2-VAScscores were associated with poorer performance, though not independently of their own components.”

    HumansHospitalized patients with atrial fibrillation; association was not independent of score componentsn = 62

    Cognitive Impairment and Functional Independence in Hospitalized Patients with Atrial Fibrillation: A Cross-Sectional Study

    Journal of clinical medicine

Survival

downin humans1

1 study
  1. CHA2DS2-VASc score is associated with survival in humans (patients turned down for elective AAA repair) (P = 0.05).

    “higher CHA2DS2-VASc scores were independently associated with reduced survival at 3 years (P = 0.001 and P = 0.05, respectively)”

    Humanspatients turned down for elective AAA repair3 yearsn = 286

    Predicting Survival for Patients Turned down for Elective Abdominal Aortic Aneurysm Repair: Results of a UK Study and the Effectiveness of the CHA₂DS₂-VASc Score

    Annals of vascular surgery

Mild cognitive impairment

upin humans1OR 1.27

1 study
  1. CHA2DS2-VASc score is associated with mild cognitive impairment in humans (atrial fibrillation; CHA2DS2-VASc score ≥ 2 versus < 2 points) (OR 1.27, 95% CI 1.22–1.33; ≥ 2 versus < 2 points).

    “A higher CHA2DS2-VASc score (OR = 1.27, 95% CI: 1.22-1.33, P < 0.001; ≥ 2 points vs. < 2 points)”

    Humansatrial fibrillation; CHA2DS2-VASc score ≥ 2 versus < 2 points64.7% malesn = 4,136

    Cognitive function disparities among atrial fibrillation patients with varying comorbidities

    Journal of geriatric cardiology : JGC

More on Mild cognitive impairment

1-year survival

mixedin humans1

1 study
  1. CHA2DS2-VASc score is associated with 1-year survival in humans (Incident atrial fibrillation).

    “The CHA2DS2-VASc score associated strongly with 1-year survival (p<0.0001).”

    HumansIncident atrial fibrillation1 yearn = 157,658

    Temporal trends in mortality and causes of death in patients with incident atrial fibrillation: a nationwide register study from 2010 to 2018

    BMJ open

Noncardiovascular frail events

upin humans1HR 2.1

1 study
  1. CHA2DS2-VASc score is linked with a higher risk of noncardiovascular frail events in humans after adjusting for covariates in patients with AF (HR 2.1 (95% CI: 2.0-2.2)).

    “CHA2DS2-VASc, and HAS-BLED > 0 were associated with higher risk of non-cardiovascular frail events (hazard ratio [HR] 2.1 (95% CI: 2.0-2.2) for CHA2DS2-VASc 4+”

    Humansafter adjusting for covariates in patients with AF

    Association of CHA₂DS₂-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF study

    American heart journal

All-cause and cardiovascular mortality

mixedin humans1

1 study
  1. CHA2DS2-VASc score predicts all-cause and cardiovascular mortality in humans (patients with atrial fibrillation).

    “Apart from low nMHI, CHA2DS2VASC delta CHA2DS2VASC were statistically significant independent predictors of both all-cause and CV mortality.”

    Humanspatients with atrial fibrillationmedian follow-up 4.6 yearsn = 4,616

    The association of disparities in neighborhood median household income and mortality in patients admitted to the hospital with atrial fibrillation

    Progress in cardiovascular diseases

Diastolic hypotension

upin humans1OR 1.518

1 study
  1. CHA2DS2-VASc score is linked with a higher risk of diastolic hypotension in fit hypertensive individuals (OR = 1.518, 95% CI: 1.161-1.985, P = 0.002).

    “CHA2DS2VASc score was independently associated with night-time mean diastolic values < 65 mmHg (OR = 1.518, 95% CI: 1.161-1.985; P = 0.002)”

    Humansin fit hypertensive individualsn = 174

    Ambulatory diastolic blood pressure: a marker of comorbidity in elderly fit hypertensive individuals?

    Journal of geriatric cardiology : JGC

More on Diastolic hypotension

Lifespan

downin humans1

1 study
  1. CHA2DS2-VASc score is associated with lifespan in humans (coronary artery disease and atrial fibrillation) (1-year: 96.4% to 85.7%; 5-year: 78.4% to 50.0%).

    “With the increase in the CHA2DS2-VASc score, the 1-year and 5-year survival rate decreased”

    Humanscoronary artery disease and atrial fibrillationn = 1,579

    Assessment of the CHA₂DS₂-VASc Score for the Prediction of Death in Elderly Patients With Coronary Artery Disease and Atrial Fibrillation

    Frontiers in cardiovascular medicine

All 12

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 4Mar 2026: 6Apr 2026: 1May 2026: 1Jun 2026: 3Jul 2026: 3Aug 2026: 1Sep 2026: 2Oct 2026: 7Nov 2026: 438 papers in 12 months
ESC Congress 2026 Abstract

Sleep apnea linked to higher combined death, heart and stroke risk

Over an average 3.1 years, death, heart attack, stroke or heart-failure hospitalization occurred in 24.3% with sleep apnea versus 17.2% below the study’s threshold.Over an average 3.1 years, death, heart attack, stroke or heart-failure hospitalization occurred in 24.3% with sleep apnea versus 17.2% below the study’s threshold.

Cohort · 1,053 peopleStroke
ESC Congress 2026 Abstract

Faster biological aging is linked to worse heart outcomes

In 31,092 people with atrial fibrillation, an irregular heartbeat, followed for an average of 699 days, faster biological aging was linked to increased complications and…In 31,092 people with atrial fibrillation, an irregular heartbeat, followed for an average of 699 days, faster biological aging was linked to increased complications and death.

Cohort · 31,092 peopleBiomarkers

See all 92 papers on CHA2DS2-VASc score